Skip to main content
HR 7017 116th Congress House Health Cardiovascular and respiratory health Drug safety, medical device, and laboratory regulation Emergency medical services and trauma care Health technology, devices, supplies Infectious and parasitic diseases Medical tests and diagnostic methods State and local government operations

Right to Test Act

Introduced: May 26, 2020 See on congress.gov
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 26, 2020
Referred to the House Committee on Energy and Commerce.
May 26, 2020
Introduced in House
 Plain-English summary Congressional Research Service

Right to Test Act

This bill authorizes a state's public health department, or another entity designated by the state's governor, to approve a diagnostic test or diagnostic device (e.g., a test for the virus that causes COVID-19, or coronavirus disease 2019) for use during a public health emergency.

Unless requested by the governor of the state, the Food and Drug Administration (FDA) may not, during the emergency, engage in certain enforcement actions related to such a test or device.

Not later than 180 days following the end of the public health emergency, the FDA must review and make a final determination concerning approval of the test or device.

What's happening now May 26, 2020

Referred to the House Committee on Energy and Commerce.

 Committees of jurisdiction 1